Landmark Prospective Evidence on Posterior Approach to SI Joint Fusion Reflects Improved Pain Scores at 6 & 12 Months
Press release content from PR Newswire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Dawood Sayed. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
TAMPA, Fla., Jan. 25, 2022 /PRNewswire/ -- Preliminary data from the landmark SI joint fusion study of Tampa-based medical device company, PainTEQ...
/PRNewswire/ -- Stratus™ Medical, a company focused on advancing radiofrequency (RF) ablation treatment for chronic pain, announced three new patents today....
/PRNewswire/ -- A new multicenter real-world study of PainTEQ's LinQ device reflected long-term success and safety in treating sacroiliac (SI) joint...
Share this article Share this article SAN DIEGO, May 27, 2021 /PRNewswire/ -- NeuraLace Medical, Inc., a medical device company focused on improving pain relief among patients suffering from debilitating chronic nerve pain, announced today that the first patient has been enrolled as part of the AXON-RCT U.S. study: a prospective, randomized, controlled clinical trial comparing the safety and effectiveness of Axon Therapy® for post-traumatic peripheral neuropathic pain to conventional medical management. The Primary Investigator of the study will be Dr. Leonardo Kapural of the Carolinas Pa...